Raelene Jane Pickering

Title: Raelene Jane Pickering: Innovator in Glycation Research

Introduction

Raelene Jane Pickering is a prominent inventor based in Clayton, Australia. She has made significant contributions to the field of glycation research, particularly through her innovative patents. With a total of three patents to her name, her work focuses on the modulation of the Receptor for Advanced Glycation End-products (RAGE).

Latest Patents

Raelene's latest patents include groundbreaking methods for screening candidate agents that can modulate RAGE activity. One of her notable patents describes a method of screening candidate agents for their ability to modulate RAGE activity induced by an active co-located GPCR. This method involves contacting a RAGE polypeptide with a GPCR polypeptide in the presence of a candidate agent, followed by detecting whether the candidate agent modulates RAGE activation. Another significant patent involves an isolated or purified AON for modifying pre-mRNA splicing in RAGE, aimed at modulating the splicing of the RAGE gene transcript.

Career Highlights

Throughout her career, Raelene has worked with esteemed institutions such as Beijing University of Technology and Murdoch University. Her research has been pivotal in advancing the understanding of RAGE and its implications in various diseases.

Collaborations

Raelene has collaborated with notable colleagues, including Merlin Christopher Thomas and Carlos Rosado. These partnerships have further enriched her research and contributed to her innovative work in the field.

Conclusion

Raelene Jane Pickering stands out as a significant figure in glycation research, with her patents paving the way for new therapeutic approaches. Her contributions continue to influence the scientific community and enhance our understanding of RAGE.